This training session focus on Acute Lymphoblastic Leukemia Schema using the PDCS

This session will explore strategies for enhancing the quality of cancer reporting through effective quality control measures. Expert panelists will share insights on key aspects of data quality in cancer reporting, including the development of data quality plans and the diverse approaches used by cancer registries. Key topics include: • Data Quality: The significance of accurate, consistent, and timely cancer data, along with best practices to ensure data integrity throughout the reporting process. • Data Quality Plans: Strategies for developing comprehensive data quality plans that align with regulatory standards and enhance reporting accuracy. • Comparative Approaches in Cancer Registries: Examining various methods adopted by different registries to maintain high-quality data, with a focus on opportunities for improvement and standardization. The session will also feature an interactive breakout discussion, allowing participants to share experiences, address challenges, and collaborate on solutions to improve cancer reporting practices.

This "How To" webinar is the NAACCR Version 24 update for creating census tract-level SEER*Stat databases to support spatial analysis and health equity research. This presentation will go through step by step how to handle the NAACCR Version 24 incidence data, census tract-level population estimates, and the area-based social measures data. Mortality data will also be touched on. This webinar is appropriate for registry analysts, academic researchers, and anyone interested in the use of cancer registry data.

Join us for a special roundtable discussion on the NAACCR Mentorship Program's newest offering: Mentorship Cohorts. These small, facilitator-led groups provide a unique, interactive space for growth, learning, and mutual support. Each cohort fosters an environment of active participation, allowing members to guide and inspire each other along their career paths. During this roundtable, we'll cover: • Objectives of Mentorship Cohorts • Proposed Cohort Structures • Guidelines for Participation • Small Group Discussion Opportunities

This instructional webinar will cover the NAACCR Call for Data process and will highlight critical changes for this year, including new data items and the required tumor-level de-duplication protocol. It is important that at least one staff person from each central registry attend. This webinar will be recorded and available for review on the Call for Data Page. Call for Data Timeline 2024: • Aug 26th CFD Instructional Webinar • Sept 1st CFD Resources available on the NAACCR Call for Data Webpage: https://www.naaccr.org/call-for-data/ • First week of Sept: Match*Pro ver 2.5 release • First week of Oct: NAACCR*Prep release (also File*Pro) • Nov 1st CFD Portal Opens • Dec 3rd NAACCR CFD Due If you have any questions, please reach out Recinda Sherman, Program Manager of Data Use and Research.

During our March roundtable, we'll review the latest updates to the Death Clearance Manual. Additionally, various registries will showcase their Death Clearance procedures, which may include utilizing Web Plus for followback and leveraging Health Information Exchange Data.

Adolescent and Young Adult (AYA) Oncology: The insights gained from the Malignant Germ Cell International Consortium (MaGIC). Dr. A. Lindsay Frazier, MD One of the most common adolescent and young adult (AYA) cancers are the cell tumors (GCTs), however no significant change has happened to GCTs treatments protocols in the last decades. The Malignant Germ Cell International Consortium (MaGIC) brings together the world’s leading experts in germ cell tumors (GCTs), from across the spectrum of cancer research, with the shared goal of developing more effective treatments for GCTs through scientific inquiry. As the lead of the Malignant Germ Cell Tumor International Consortium, Dr Lindsay will discuss AYA Oncology and share important lessons learned in the field of GCT research. Forecasting for Accurate Procurement of Pediatric Chemotherapies. Dr. Shrivastava, MD, MPH Forecasting the cost and quantities of pediatric chemotherapies is an essential part of ensuring a reliable supply of essential medicines for the care of children with cancer. Dr. Shrivastava will describe the importance of access to accurate registry data and its relevance today amongst several critical drug shortages.

Three presentations with a focus on applications of Artificial Intelligence (AI) and Natural Language Processing (NPL) in the cancer registry field.

This two-part series is presented by CDC colleagues who are on the forefront of a number of initiatives in the rapidly developing area of public health interoperability. This educational series was presented at the NAACCR annual conference in June 2023 and, due to popular demand, is being offered as a "replay" for the entire NAACCR community. These two sessions will provide an overview of key interoperability terms and an update on current initiatives that will impact public health and cancer surveillance in particular. These initiatives are intended to improve health data exchange and quality across healthcare. Topics will include benefits and potential implications for registries. There will be time for questions and answers throughout both sessions.

The NAACCR Professional Development Steering Committee Upkeep Task Force revised the Oncology Data Specialist Training Guide. This presentation will review the revisions and the goals of the guide.